Project Title | Principal Investigator | Position |
| Cancer | ||
| Nanoscale Formulations of the Anticancer Agent Docetaxel | Dr. Pieter Cullis | CDRD Scientific Director and Professor, Dept. of Biochemistry & Molecular Biology, UBC |
| Inhibition of Autophagy using siRNA | Dr. Sharon Gorski | BC Genome Sciences Centre and Associate Professor, Biochemistry & Molecular Biology, SFU |
| Chemical Inhibitors of Autophagy as New Cancer Therapy Agents | Dr. Michel Roberge | Professor, Dept. of Biochemistry & Molecular Biology, UBC |
| Ceratamines, Microtubule-Stabilizing Antitumour Agents | Dr. Raymond Andersen | Professor, Dept. of Earth & Ocean Sciences, UBC |
| MicroRNAs as Therapeutic Agents in Acute Myeloid Leukemia | Dr. Keith Humphries | Professor, Pathology & Lab Medicine, BC Cancer Agency, UBC |
| Intravesicular Paclitaxel for Bladder Cancer | Dr. Helen Burt | CDRD Division Head and Professor, Faculty of Pharmaceutical Sciences, UBC |
| Identification of Tdp1 Inhibitors for Treatment of SCAN1 and Cancer | Dr. Cornelius Boerkoel | Associate Professor, Medical Genetics, Faculty of Medicine |
| Development of Irinophore C for the treatment of colorectal cancer | Dr. Dawn Waterhouse | British Columbia Cancer Agency |
| Neurological Disease | ||
| Therapeutic Strategies for Huntington’s Disease | Dr. Michael Hayden | Director/Professor, Centre for Molecular Medicine & Therapeutics, UBC |
| Metabolic Disease | ||
| An Enzyme Inhibitor for Treating Type-2 Diabetes | Dr. Andrew Bennet | Professor, Dept. of Chemistry, SFU |
| α-Amylase Inhibitors for Type-2 Diabetes | Dr. Stephen Withers | Professor, Dept. of Chemistry, UBC |
| Tetrahydroxylated Bile Acids as Novel Choleretic Agents | Dr. Victor Ling | Professor, Department of Biochemistry and Molecular Biology, UBC, Department Head, Cancer Genetics, BC Cancer Agency |
| Inhibition of IAPP Accumulation as a Treatment Approach for diabetes | Dr. Bruce Verchere | Associate Professor, Dept. of Pathology and Laboratory Medicine, UBC |
Dr. Paul Fraser | Professor, Dept. of Medical Biophysics, University of Toronto | |
| Infectious Disease | ||
| Formulation of Cationic Peptides for Systemic Use | Dr. Robert Hancock | Professor, Dept. of Microbiology & Immunology, UBC |
| Other | ||
| Selective EP4 Agonists for the Treatment of Inflammatory Bowel Diseases | Dr. Robert Young | Professor, Dept. of Chemistry, SFU |
| Selective Peptide Inhibitors of TGF-β1 Activation For The Treatment of Idiopathic Pulmonary Fibrosis | Dr. Nasreen Khalil | Clinical Professor of Medicine, The Lung Centre, Gordon and Leslie Diamond Health Care Centre |
| Inhibition of Granzyme B for Treatment of Abdominal Aortic Aneurysms | Dr. David Granville | Assistant Professor, Dept. of Pathology and Laboratory Medicine, UBC |